Data Element

Travel History Location
Description

A location in a person’s travel history either as an address or as a coded location.

Comment

CDC's Consolidated Comment for USCDI v4

  • To align with the most current value set available, please update USCDI Level 2/Comment value set for Travel Purpose: (https://www.healthit.gov/isa/taxonomy/term/3616/comment) to the PHIN VADS value set for Travel Purpose PHVS_TravelPurpose_CDC
  •  Comments from NACCHO: NACCHO recommends inlcusion of this data element. NACCHO expects this field to be added to the USCDI v4 Core. This data element will support the early and rapid identification of potential disease outbreaks.

CDC's Consolidated Comment

  • Strongly recommend inclusion of this data element along with travel history dates as part of USCDI v3. Not only is this information important for public health, but also plays an important role in developing a differential diagnosis list as some infectious diseases are more common or only found internationally. Additionally, these concepts are built into national case notifications to CDC for 25 reportable conditions using the case notification HL7 message mapping guide format. Anticipate within the next couple of years to make travel history available for all notifiable conditions as it is not only important for general surveillance, but also for work done at CDC related to global migration and quarantine e.g., it helps to identify post-exposure prophylaxes needs and plays critical role in outbreak response such as Ebola and/or early SARS-CoV-2 response.

CSTE Comment:

  • Agree with CDC: Strongly recommend inclusion of this data element along with travel history location as part of USCDI v3. Not only is this information important for public health, but also plays an important role in developing a differential diagnosis list as some infectious diseases are more common or only found internationally. Additionally, these concepts are built into national case notifications to CDC for 25 reportable conditions using the case notification HL7 message mapping guide format. Anticipate within the next couple of years to make travel history available for all notifiable conditions as it is not only important for general surveillance, but also for work done at CDC related to global migration and quarantine e.g., it helps to identify post-exposure prophylaxes needs and plays critical role in outbreak response such as Ebola and/or early SARS-CoV-2 response.
  • For travel history it  is important to capture the dates the person was in the location/destination (start date and end date) - also important to phrase the question so that it does not always represent travel FROM the US to another country and back as many individuals who may have been residing in another country or another relevant location may present for care. Recommend the question be asked as whether time was spent recently in a foreign country or another location outside of the jurisdiction.

Unified Comment from CDC

  • CDC considers this element to be high priority and strongly recommends its inclusion in the USCDI V3
     
  • CSTE supports inclusion of this measure into USCDI v3: Indicating international travel flag and country visited (with dates of travel and return to US) would be beneficial for some diseases. In general, public health would capture this information during a case investigation and think it might be a burden for clinical care to capture ALL travel (domestic and international) but in some cases, charts are reviewed for travel or the provider is interviewed for patient travel hx, so agree this is useful for some conditions

Log in or register to post comments